Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octreotide for Food Intake after Upper GI Surgery
NCT02385617Completed
- Sponsor
- St James's Hospital
- Start
- Jan 2014
- Primary completion
- Dec 2017
- Modality
- Peptides
- Countries
- 2
01
Overview
Randomised, double-blind trial of Octreotide long-acting injection in early satiety and Malnutrition (4 arms), sponsored by St James's Hospital. Primary endpoint: Ad libitum calorie intake at 1 hour. Started Jan 2014; status: completed.
02
Drugs
Octreotide long-acting injection
03
Conditions
early satietyMalnutrition
Beyond the preview
Go deeper on NCT02385617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02385617.